Fig 1: (A) The expression distribution of risk score IRGs in the short-survival time group and the long-survival time group. The asterisks represent levels of significance *p < 0.05, ns: not statistically significant. (B) Western blot analysis of four differentially expressed IRGs in the signature model. The protein expression level of TNC in the short survival group was significantly upregulated, and the protein expression level of SSTR2 was significantly downregulated. There was no significant difference in the expression of SERPINA3 and TNFRSF19 between the two groups. (C) High expression of SSTR2 was negatively related to tumor invasion, EMT and metastasis. (D) High expression of TNV was positively related to tumor metastasis and hypoxia.
Supplier Page from Abcam for Anti-Somatostatin Receptor 2 antibody - C-terminal